Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2024 to 29 February 2024 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC, Article 38 of Directive 2001/82/EC or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)
Linked as:
Extract
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2024 to 29 February 2024 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC, Article 38 of Directive 2001/82/EC or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)
No longer available (Autolink)
See the full content of this document
Core Citations
WORK EXPRESSION OF in
This document cites
- Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
- Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
- Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)Text with EEA relevance
